General Information
Revision date
2016-11-24
Product name
Rabeprazole Sodium Delayed-Release Tablet
Manufacturer Name
Lupin Limited
Icons in SDS
Company Information
company name
Lupin Limited
Section 2
SECTION 2: Hazards identification
Fire and Explosion Expected to be non-combustible. Health Rabeprazole sodium delayed-release tablets are contraindicated in patients with known hypersensitivity to rabeprazole, substituted benzimidazoles, or to any component of the formulation. Hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, and urticarial. PPIs, including rabeprazole sodium delayed-release tablets, are contraindicated with rilpivirine-containing products.
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.
